TUCSON, Ariz., Sept. 12, 2016 -- Medicine is being “fundamentally transformed” into an unaffordable, complex, adversarial, depersonalized labyrinth, writes dermatologist Melinda Woofter, M.D., of Granville, Ohio, in the fall issue of the Journal of American Physicians and Surgeons. Dr. Woofter is currently president of the Association of American Physicians and Surgeons (AAPS).
The direct reason for the unsustainable system, she writes, is government distortion of the marketplace, destroying cost transparency: “Government control of resources always leads to less for everyone. Without natural price signals for market adjustments, costs soar as resources are wrongly allocated, wasted, and squandered.”
In an effort to fix the problem it caused, government resorts to further price controls and still more coercion and restrictions, she explains. Solutions are difficult to find because “government powerholders and third-party cronies who benefit from this will not give up their stranglehold on medicine.”
Dr. Woofter recommends a short new primer analyzing the causes of the high costs and deteriorating quality of American medicine: Common Sense Medicine: Restoring the Patient/Physician Relationship by Jeff Danby. The key is not to pass more laws and regulations, but to restore natural price discovery between patients and doctors, Danby writes.
The Journal of American Physicians and Surgeons is published by the Association of American Physicians and Surgeons (AAPS), a national organization representing physicians in all specialties since 1943.
Contact: Jane M. Orient, M.D., (520) 323-3110, janeorientmd@gmail., or Melinda Woofter, M.D., [email protected]


Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
First Western Ship Transits Strait of Hormuz Since Iran War Began
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 



